zur Navigation zum Inhalt
 
Onkologie 27. Jänner 2014

Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions

In the past years, new emerging targeted therapies against specific markers have revolutionized the field of treating malignancies. In this article, we discuss the first available agent that targets a specific molecule in acute myeloid leukemia, as well as the future possibilities that genetic research unveil.

Spyridon Dimitrios Chondropoulos, Annaliza Delastic, Alexandros Spyridonidis, memo - Magazine of European Medical Oncology 4/2013

Volltext dieses Beitrags / entire article auf SpringerLink

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben